WASHINGTON, Nov 30 (Reuters) - The U.S. Food and Drug Administration issued a health alert on Wednesday over the use of Genzyme Corp. and Schering AG’s drug Campath in a clinical trial to treat multiple sclerosis.
WASHINGTON, Nov 30 (Reuters) - The U.S. Food and Drug Administration issued a health alert on Wednesday over the use of Genzyme Corp. and Schering AG’s drug Campath in a clinical trial to treat multiple sclerosis.
